Literature DB >> 6108045

Transfer of lorazepam and its conjugate across the human placenta.

J Kanto, L Aaltonen, P Liukko, K Mäenpää.   

Abstract

The concentrations of lorazepam and its conjugate were determined in maternal venous serum, in umbilical vein and artery serum, and in amniotic fluid after a single 2 mg intramuscular and 2.5 mg oral maternal administration. During normal delivery (2 mg intramuscular injection) and caesarean section (2.5 mg orally) both the unconjugated and conjugated forms of lorazepam were found in the umbilical circulation and amniotic fluid. The serum protein unbound fraction was 14.0 +/- 4.8 (S.D.) % in maternal circulation and 20.8 +/- 3.1% in umbilical circulation. Generally, lorazepam was a useful anxiolytic agent during normal delivery and as a sedative on the night before caesarean section.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6108045     DOI: 10.1111/j.1600-0773.1980.tb01852.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  4 in total

1.  Placental transfer of flunitrazepam following intramuscular administration during labour.

Authors:  J Kanto; R Erkkola; L Kangas; Y Pitkänen
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

Review 2.  The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state.

Authors:  M D Hill; F P Abramson
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

Review 3.  Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations.

Authors:  J H Kanto
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

4.  Effect of maternal lorazepam on the neonate.

Authors:  A G Whitelaw; A J Cummings; I R McFadyen
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.